This intricate regulatory network offers a compelling rationale for microbiota-targeted strategies (e.g., probiotic-induced SCFA enhancement) to concurrently dampen TLR4-initiated inflammation and NLRP3-amplified responses, ultimately ameliorating fibrotic remodeling in DN. Here, NLRP3 is linked to liver dysplastic nodule.